ID

44585

Descrizione

DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral); ODM derived from: https://clinicaltrials.gov/show/NCT02156570

collegamento

https://clinicaltrials.gov/show/NCT02156570

Keywords

versioni (2)
  1. 01/06/20 01/06/20 -
  2. 27/09/21 27/09/21 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

27 settembre 2021

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Hepatitis C NCT02156570

Inglese

Eligibility Hepatitis C NCT02156570

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
provision of written informed consent
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
male and female patients aged 18 years and above
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
willing to use two effective methods of contraception during the treatment period and 24 weeks post.
Descrizione

Contraceptive methods Quantity

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C1265611
hbsag negative
Descrizione

Hepatitis B surface antigen negative

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0919711
detectable hcv rna at screening (>10,000 iu/ml), and in the opinion of the investigator is unlikely to demonstrate spontaneous viral clearance
Descrizione

Hepatitis C virus RNA assay

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1272251
compensated liver disease (child-pugh a)
Descrizione

Compensated liver disease Child-Pugh Classification

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3839044
UMLS CUI [1,2]
C4050412
negative pregnancy test at screening and 24 hours prior to first dose of study drugs
Descrizione

Pregnancy test negative

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0427780
medically stable on the basis of physical examination, medical history and vital signs
Descrizione

Stable status Medical Physical Examination | Stable status Medical History | Stable status Medical Vital signs

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0205360
UMLS CUI [1,2]
C0205476
UMLS CUI [1,3]
C0031809
UMLS CUI [2,1]
C0205360
UMLS CUI [2,2]
C0205476
UMLS CUI [2,3]
C0262926
UMLS CUI [3,1]
C0205360
UMLS CUI [3,2]
C0205476
UMLS CUI [3,3]
C0518766
adequate english to provide reliable responses to the study questionnaires
Descrizione

Language ability English | Questionnaires Completion

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1145677
UMLS CUI [1,2]
C0376245
UMLS CUI [2,1]
C0034394
UMLS CUI [2,2]
C0205197
recent hepatitis c infection, as defined by: a) i) first anti-hcv ab or hcv rna positive within the previous 6 months and ii) documented anti-hcv ab negative within the 24 months prior to anti-hcv antibody positive result, or b) i) first anti-hcv ab or hcv rna positive within the previous 6 months and ii) acute clinical hepatitis (jaundice or alt> 10 x uln) within the previous 12 months prior to first positive hcv antibody or hcv rna, with no other cause of acute hepatitis identifiable
Descrizione

Hepatitis C | Hepatitis C Antibody First | Hepatitis C RNA positive | Hepatitis C antibody negative | Status pre- Hepatitis C antibody positive | Hepatitis | Icterus | Alanine aminotransferase increased

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019196
UMLS CUI [2,1]
C0166049
UMLS CUI [2,2]
C0205435
UMLS CUI [3]
C0855842
UMLS CUI [4]
C0853904
UMLS CUI [5,1]
C0332152
UMLS CUI [5,2]
C0281863
UMLS CUI [6]
C0019158
UMLS CUI [7]
C0022346
UMLS CUI [8]
C0151905
if co-infection with hiv is documented, the subject must meet the following criteria:
Descrizione

HIV coinfection | Criteria Fulfill

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4062778
UMLS CUI [2,1]
C0243161
UMLS CUI [2,2]
C1550543
antiretroviral (arv) untreated for >8 weeks preceding screening visit with cd4 t cell count >500 cells/mm3 or
Descrizione

Antiretroviral therapy Absent | Absolute CD4 T cell count

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1963724
UMLS CUI [1,2]
C0332197
UMLS CUI [2]
C0519835
on a stable arv regimen for >8 weeks prior to screening visit, with cd4 t cell count >200 cells/mm3 and an undetectable plasma hiv rna level.
Descrizione

Antiretroviral therapy Stable | Absolute CD4 T cell count | Plasma HIV RNA undetectable

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1963724
UMLS CUI [1,2]
C0205360
UMLS CUI [2]
C0519835
UMLS CUI [3,1]
C0032105
UMLS CUI [3,2]
C0877598
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
standard exclusions to rbv therapy
Descrizione

Standard Exclusion Ribavirin

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1442989
UMLS CUI [1,2]
C2828389
UMLS CUI [1,3]
C0035525
pregnancy/lactation or male subjects whose female partners are pregnant
Descrizione

Pregnancy | Breast Feeding | Gender Partner Pregnancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C0079399
UMLS CUI [3,2]
C0682323
UMLS CUI [3,3]
C0032961
subject has a history of decompensated liver disease: history of ascites, hepatic encephalopathy, or bleeding oesophageal varices, and/or any of the following screening laboratory results: a.inr of ≥1.5; serum albumin <3.3 g/dl; serum total bilirubin >1.8 times upper limit of normal, unless isolated in subjects with gilbert's syndrome.
Descrizione

Decompensated liver disease | Ascites | Hepatic Encephalopathy | Bleeding esophageal varices | INR | Serum albumin measurement | SERUM TOTAL BILIRUBIN ELEVATED | Exception Gilbert Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4075847
UMLS CUI [2]
C0003962
UMLS CUI [3]
C0019151
UMLS CUI [4]
C0155789
UMLS CUI [5]
C0525032
UMLS CUI [6]
C0523465
UMLS CUI [7]
C0595866
UMLS CUI [8,1]
C1705847
UMLS CUI [8,2]
C0017551
Ritorna all'inizio della pagina

Similar models

Eligibility Hepatitis C NCT02156570

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
provision of written informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
male and female patients aged 18 years and above
boolean
C0001779 (UMLS CUI [1])
Contraceptive methods Quantity
Item
willing to use two effective methods of contraception during the treatment period and 24 weeks post.
boolean
C0700589 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Hepatitis B surface antigen negative
Item
hbsag negative
boolean
C0919711 (UMLS CUI [1])
Hepatitis C virus RNA assay
Item
detectable hcv rna at screening (>10,000 iu/ml), and in the opinion of the investigator is unlikely to demonstrate spontaneous viral clearance
boolean
C1272251 (UMLS CUI [1])
Compensated liver disease Child-Pugh Classification
Item
compensated liver disease (child-pugh a)
boolean
C3839044 (UMLS CUI [1,1])
C4050412 (UMLS CUI [1,2])
Pregnancy test negative
Item
negative pregnancy test at screening and 24 hours prior to first dose of study drugs
boolean
C0427780 (UMLS CUI [1])
Stable status Medical Physical Examination | Stable status Medical History | Stable status Medical Vital signs
Item
medically stable on the basis of physical examination, medical history and vital signs
boolean
C0205360 (UMLS CUI [1,1])
C0205476 (UMLS CUI [1,2])
C0031809 (UMLS CUI [1,3])
C0205360 (UMLS CUI [2,1])
C0205476 (UMLS CUI [2,2])
C0262926 (UMLS CUI [2,3])
C0205360 (UMLS CUI [3,1])
C0205476 (UMLS CUI [3,2])
C0518766 (UMLS CUI [3,3])
Language ability English | Questionnaires Completion
Item
adequate english to provide reliable responses to the study questionnaires
boolean
C1145677 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0034394 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
Hepatitis C | Hepatitis C Antibody First | Hepatitis C RNA positive | Hepatitis C antibody negative | Status pre- Hepatitis C antibody positive | Hepatitis | Icterus | Alanine aminotransferase increased
Item
recent hepatitis c infection, as defined by: a) i) first anti-hcv ab or hcv rna positive within the previous 6 months and ii) documented anti-hcv ab negative within the 24 months prior to anti-hcv antibody positive result, or b) i) first anti-hcv ab or hcv rna positive within the previous 6 months and ii) acute clinical hepatitis (jaundice or alt> 10 x uln) within the previous 12 months prior to first positive hcv antibody or hcv rna, with no other cause of acute hepatitis identifiable
boolean
C0019196 (UMLS CUI [1])
C0166049 (UMLS CUI [2,1])
C0205435 (UMLS CUI [2,2])
C0855842 (UMLS CUI [3])
C0853904 (UMLS CUI [4])
C0332152 (UMLS CUI [5,1])
C0281863 (UMLS CUI [5,2])
C0019158 (UMLS CUI [6])
C0022346 (UMLS CUI [7])
C0151905 (UMLS CUI [8])
HIV coinfection | Criteria Fulfill
Item
if co-infection with hiv is documented, the subject must meet the following criteria:
boolean
C4062778 (UMLS CUI [1])
C0243161 (UMLS CUI [2,1])
C1550543 (UMLS CUI [2,2])
Antiretroviral therapy Absent | Absolute CD4 T cell count
Item
antiretroviral (arv) untreated for >8 weeks preceding screening visit with cd4 t cell count >500 cells/mm3 or
boolean
C1963724 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0519835 (UMLS CUI [2])
Antiretroviral therapy Stable | Absolute CD4 T cell count | Plasma HIV RNA undetectable
Item
on a stable arv regimen for >8 weeks prior to screening visit, with cd4 t cell count >200 cells/mm3 and an undetectable plasma hiv rna level.
boolean
C1963724 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0519835 (UMLS CUI [2])
C0032105 (UMLS CUI [3,1])
C0877598 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Standard Exclusion Ribavirin
Item
standard exclusions to rbv therapy
boolean
C1442989 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C0035525 (UMLS CUI [1,3])
Pregnancy | Breast Feeding | Gender Partner Pregnancy
Item
pregnancy/lactation or male subjects whose female partners are pregnant
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0682323 (UMLS CUI [3,2])
C0032961 (UMLS CUI [3,3])
Decompensated liver disease | Ascites | Hepatic Encephalopathy | Bleeding esophageal varices | INR | Serum albumin measurement | SERUM TOTAL BILIRUBIN ELEVATED | Exception Gilbert Disease
Item
subject has a history of decompensated liver disease: history of ascites, hepatic encephalopathy, or bleeding oesophageal varices, and/or any of the following screening laboratory results: a.inr of ≥1.5; serum albumin <3.3 g/dl; serum total bilirubin >1.8 times upper limit of normal, unless isolated in subjects with gilbert's syndrome.
boolean
C4075847 (UMLS CUI [1])
C0003962 (UMLS CUI [2])
C0019151 (UMLS CUI [3])
C0155789 (UMLS CUI [4])
C0525032 (UMLS CUI [5])
C0523465 (UMLS CUI [6])
C0595866 (UMLS CUI [7])
C1705847 (UMLS CUI [8,1])
C0017551 (UMLS CUI [8,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial